 | | PRD_001251 | | Name: | ACE-PHE-ALA-THR-ALA-0QE | | Formula: | C22 H31 Cl N4 O6 | | Definition date: | 2014-09-24 | | Last modified: | 2014-09-24 |
|
 | | PRD_001252 | | Name: | ACE-ILE-ALA-THR-ALA-0QE | | Formula: | C19 H33 Cl N4 O6 | | Definition date: | 2014-09-24 | | Last modified: | 2014-09-24 |
|
 | | PRD_002089 | | Name: | (1R,2S,19S,22R,34S,37R,40S,52S)-2-{[(2R,3S,4R,5R,6R)-3-(acetylamino)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-22-amino-5,15-dichloro-64-({(2R,3R,4S,5S,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(8-methylnonanoyl)amino]tetrahydro-2H-pyran-2-yl}oxy)-26,31,44,49-tetrahydroxy-21,35,38,54,56,59-hexaoxo-47-{[(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-7,13,28-trioxa-20,36,39,53,55,58-hexaazaundecacyclo[38.14.2.2~3,6~.2~14,17~.2~19,34~.1~8,12~.1~23,27~.1~29,33~.1~41,45~.0~10,37~.0~46,51~]hexahexaconta-3,5,8(64),9,11,14,16,23(61),24,26,29(60),30,32,41(57),42,44,46,48,50,62,65-henicosaene-52-carboxylic acid (non-preferred name) | | Formula: | C88 H97 Cl2 N9 O33 | | Definition date: | 2014-09-10 | | Last modified: | 2014-09-10 |
|
 | | PRD_001158 | | Name: | Teicoplanin pseudoaglycone | | Formula: | C78 H79 Cl2 N9 O32 | | Definition date: | 2014-09-03 | | Last modified: | 2014-09-03 |
|
 | | PRD_001169 | | Name: | Teicoplanin pseudoaglycone | | Formula: | C88 H97 Cl2 N9 O33 | | Definition date: | 2014-09-03 | | Last modified: | 2014-09-03 |
|
 | | PRD_002101 | | Name: | N-[(6R,9S,10R,13S,15aR,22S,24aR)-22-[4-(dimethylamino)benzyl]-6-ethyl-10,23-dimethyl-18-(morpholin-4-ylmethyl)-5,8,12,15,21,24-hexaoxo-13-phenyl-1,2,3,5,6,7,8,9,10,13,14,15,15a,16,19,21,22,23,24,24a-icosahydro-12H-pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecin-9-yl]-3-hydroxypyridine-2-carboxamide | | Formula: | C50 H63 N9 O10 | | Definition date: | 2014-07-30 | | Last modified: | 2014-07-30 |
|
 | | PRD_001171 | | Name: | Serine protease inhibitor BEZ-NLE-LYS-ARG-M9P | | Formula: | C32 H57 F3 N11 O5 | | Definition date: | 2014-07-08 | | Last modified: | 2014-07-08 |
|
 | | PRD_002092 | | Name: | L-alanyl-3,5-dibromo-L-tyrosyl-L-alanine | | Formula: | C15 H19 Br2 N3 O5 | | Definition date: | 2014-07-08 | | Last modified: | 2014-07-08 |
|
 | | PRD_001078 | | Name: | Peptide inhibitor MPT-DPP-DAR-G-DPN-NH2 | | Formula: | C23 H38 N9 O5 S | | Definition date: | 2014-06-25 | | Last modified: | 2014-06-25 |
|
 | | PRD_001162 | | Name: | Salinamide A | | Formula: | C51 H69 N7 O15 | | Description: | bicyclic depsipeptide salinamide A is a potent anti-inflammatory agent found in the marine bacterium Streptomyces sp. CNB-091. The suggested biosynthesis pathway indicates the peptide core of 1 is probably derived from the hexapeptide Thr-D-Ile-Hpg-MePhe-D-aThr-Ser (Tetrahedron Letters 39 (1998) 3915-3918). | | Definition date: | 2014-05-21 | | Last modified: | 2014-05-21 |
|
 | | PRD_001181 | | Name: | GE23077 | | Formula: | C31 H49 N9 O16 | | Definition date: | 2014-05-07 | | Last modified: | 2014-05-07 |
|
 | | PRD_001216 | | Name: | Somatostatin-14 | | Formula: | C76 H108 N18 O19 S2 | | Definition date: | 2014-05-07 | | Last modified: | 2014-05-07 |
|
 | | PRD_001059 | | Name: | Trypsin inhibitor 1 | | Formula: | C71 H104 N19 O17 S2 | | Definition date: | 2014-04-30 | | Last modified: | 2014-04-30 |
|
 | | PRD_001229 | | Name: | anti-CmABCB1 peptide | | Formula: | C100 H139 N24 O26 S | | Definition date: | 2014-04-30 | | Last modified: | 2014-04-30 |
|
 | | PRD_001097 | | Name: | Trypsin inhibitor 1 | | Formula: | C67 H106 N18 O18 S2 | | Definition date: | 2014-04-23 | | Last modified: | 2014-04-23 |
|
 | | PRD_000973 | | Name: | Trypsin inhibitor 1 | | Formula: | C71 H103 N18 O18 S2 | | Definition date: | 2014-04-09 | | Last modified: | 2014-04-09 |
|
 | | PRD_001220 | | Name: | meta-guanidinomethyl-phenylacetyl-Arg-Val-Arg-(amidomethyl)benzamidine | | Formula: | C35 H57 N15 O4 | | Definition date: | 2014-04-09 | | Last modified: | 2014-04-09 |
|
 | | PRD_001221 | | Name: | phenylacetyl-Arg-Val-Arg-(amidomethyl)benzamidine | | Formula: | C33 H52 N12 O4 | | Definition date: | 2014-04-09 | | Last modified: | 2014-04-09 |
|
 | | PRD_001086 | | Name: | Microviridin J | | Formula: | C80 H108 N19 O22 | | Definition date: | 2014-04-02 | | Last modified: | 2014-04-02 |
|
 | | PRD_001218 | | Name: | Dityromycin | | Formula: | C67 H88 N10 O16 | | Description: | DITYROMYCIN WAS CLARIFIED TO BE COMPOSED OF N-MEVAL, PRO, VAL, PHENYLGLYCINE, CH3NH2, N,N-ME2THR AND DI-ALPHA-AMINO ACID CONTAINING DIPHENYLETHER MOIETY. | | Definition date: | 2014-04-02 | | Last modified: | 2014-04-02 |
|
 | | PRD_001211 | | Name: | LEDGF peptide | | Formula: | C27 H45 N8 O9 | | Definition date: | 2013-12-25 | | Last modified: | 2014-03-25 |
|
 | | PRD_001142 | | Name: | tyrocidine A | | Formula: | C66 H87 N13 O13 | | Definition date: | 2014-03-19 | | Last modified: | 2014-03-19 |
|
 | | PRD_001219 | | Name: | Lantibiotic 107891 | | Formula: | C94 H127 Cl N26 O26 S5 | | Description: | NAI-107 IS A TETRACYCLIC PEPTIDE. POST TRANSLATIONAL MATURATION OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR, AND SER INTO DEHYDRATED AA AND THE FORMATION OF THIOETHER BONDS WITH CYSTEINE. THE CARBOXY-TERMINAL BETA-METHYLLANTHIONINE UNDERGOES DECARBOXYLATION. THIOETHER BONDS WITH CYSTEINE RESULT IN FOUR RINGS. THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND CLEAVAGE OF THE MODIFIED PRECURSOR. | | Definition date: | 2014-03-05 | | Last modified: | 2014-03-05 |
|
 | | PRD_001104 | | Name: | cyclic peptide S2iL5 | | Formula: | C90 H126 F3 N27 O23 S | | Definition date: | 2014-02-19 | | Last modified: | 2014-02-19 |
|
 | | PRD_001185 | | Name: | CONANTOKIN BK-B | | Formula: | C46 H64 N10 O25 | | Definition date: | 2014-02-19 | | Last modified: | 2014-02-19 |
|
